MPharma and the discipline behind cut CAC in half
A clear-eyed look at whether $an AI assistant can $cut CAC in half.
- The practical move an operator can make this quarter.
- What to watch next as the story develops.
- How Côte d'Ivoire's market shapes the outcome.
A clear-eyed look at whether $an AI assistant can $cut CAC in half.
- The practical move an operator can make this quarter.
- What to watch next as the story develops.
- How Côte d'Ivoire's market shapes the outcome.
For anyone building in entrepreneurship, the useful question is where this changes your costs, distribution or competition — and how soon you act on it.
AI-generated summary. It can miss nuance — read the full story above for the complete picture.
Another week, another move from mPharma — but this one changes how operators should think about pricing.
What's really being tested here is whether an AI assistant can survive contact with Côte d'Ivoire's real economy.
Why it matters
In this economy, unit economics are the strategy.
Strip away the hype and you're left with a practical question about pricing that every operator faces.
The next few months will show whether this is a durable edge or a temporary one.
What to watch next
- How Côte d'Ivoire's regulators respond over the next two quarters.
- Whether mPharma can hold margins while it chases 80% retention.
- Whether the seed round buys enough runway to reach the next milestone.
Founders watching from Casablanca should take notes: this is how you cut CAC in half.
